CTRI/2024/05/068078尚未招募3 期
Role of procalcitonin guided antibiotic initiation on the treatment outcome in acute exacerbation of Chronic obstructive pulmonary disease - NI
Bharti0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1) Patient should be a diagnosed case of COPD.
- •2) Patient should have moderate acute exacerbation of COPD according to latest GOLD guidelines 2023.
- •3) On presentation procalcitonin levels should be less than 0.1 mcg per liter.
排除标准
- •1) Mild and severe cases of acute exacerbation of COPD.
- •2) Those with lobar consolidation patch on chest X ray.
- •3) Received antibiotic for more than 48 hours at time of enrollment.
- •4) Immunocompromised patients, i.e. HIV infection, neutropenic patients (1000 × 109 per L), stem cell transplant recipients, patients of leukemia/lymphoma.
- •5) Co-existence of inflammatory conditions which can lead to increase in serum PCT levels
研究者
相似试验
尚未招募
Unknown
To evaluate the role of prolactin in guiding antibiotic treatment in patients with severe acute pancreatitisCTRI/2024/02/062457A
尚未招募
不适用
A clinical trial to see the role of procalcitonin (a blood test which detects bacterial infection) in the usage of antibiotics in acute pancreatitis patientsCTRI/2022/08/044601JIPMER
已完成
不适用
Procalcitonin-guided antibiotic therapy in acute exacerbations of chronic obstructive pulmonary disease (COPD) (AECOPD): a randomised trial - The ProCOLD StudyISRCTN77261143niversity Hospital Basel (Switzerland)200
进行中（未招募）
不适用
Monitoring of antibiotic treatment of patients with suspected sepsis using the biomarker ProcalcitoniC01.539.757SepsisRBR-99h7tcniversidade Federal de Sergipe
已完成
不适用
Registry of procalcitonin-guided antibiotic therapy in patients with lower respiratory tract infections outside of study conditions: ?Pro-REAL? - a ?real-life surveyRespiratory tract infectionsInfections and InfestationsISRCTN40854211BioMérieux (France)1,200